Serotonin Receptor Agonists: all 773 studies that test it

Page 6 of 8. Open to participants first (148), then studies with results posted, then the rest; newest registration first within each.

• Repeat Dosing of Psilocybin in Migraine HeadacheCompletedNCT04218539Phase 1
• Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in KoreanCompletedNCT04218162Phase 3
• Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerWithdrawnNCT04205071Phase 1
• Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeusStatus unknownNCT04190173Phase 3
• Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted PatientsCompletedNCT04141501Phase 2
• Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EESCompletedNCT04052776Phase 1
• Effects of Psilocybin in Anorexia NervosaCompletedNCT04052568Phase 1
• Effect of mCPP on Cognitive Control, Appetite, and Neural ResponsesTerminatedNCT03962829Not applicable
• Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy VolunteersStatus unknownNCT03937648Phase 1
• PACAP38 Induced Headache, Migraine and Flushing in Patients With MigraineCompletedNCT03881644Not applicable
• PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With RosaceaCompletedNCT03878784Not applicable
• A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine PainCompletedNCT03877718Phase 2
• LSD Therapy for Persons Suffering From Major DepressionCompletedNCT03866252Phase 2
• Effects of Acute Prucalopride Administration in Healthy VolunteersCompletedNCT03863366Not applicable
• Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral NeuropathyStatus unknownNCT03812523Phase 2
• Effects of Psilocybin in Concussion HeadacheTerminatedNCT03806985Phase 1
• Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke TrialCompletedNCT03790800Phase 3
• Mood Effects of Serotonin AgonistsCompletedNCT03790358Phase 1
• Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the SelfCompletedNCT03736980Not applicable
• Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese PatientsTerminatedNCT03720574Phase 3
• Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of ConceptCompletedNCT03715127Phase 2
• Prucalopride Treatment for Refractory Gastro-esophageal Reflux DiseaseStatus unknownNCT03676374Phase 4
• Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and AnxietyStatus unknownNCT03667677Phase 4
• A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy ParticipantsCompletedNCT03627936Phase 1
• Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinCompletedNCT03604744Early Phase 1
• Effects of Seven Day Prucalopride Administration in Healthy VolunteersCompletedNCT03572790Not applicable
• Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive DisorderActive, not recruitingNCT03554174Phase 1
• The Effect of Sumatriptan and Placebo on CGRP Induced HeadacheCompletedNCT03542357Not applicable
• TCD Monitoring Technology Guides the Precise Control of Blood Pressure After EVTStatus unknownNCT03529149Phase 4
• Buspirone for Opioid TaperingCompletedNCT03521960Phase 1
• Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under SurgeriesCompletedNCT03497351Not applicable
• Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut RecoveryCompletedNCT03477266Phase 3
• Buspirone Plus Omeprazole for Functional DyspepsiaCompletedNCT03444831Phase 4
• A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum DisordersWithdrawnNCT03432065Phase 2
• The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced HeadacheCompletedNCT03422796Not applicable
• Psilocybin and DepressionStatus unknownNCT03380442Phase 2
• Efficacy and Safety of Zolmitriptan by Sublingual AdministrationStatus unknownNCT03377257Phase 4
• Psilocybin for the Treatment of Migraine HeadacheCompletedNCT03341689Phase 1
• Psilocybin for Treatment of Obsessive Compulsive DisorderCompletedNCT03300947Phase 1
• Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy SubjectsCompletedNCT03279341Phase 4
• Rebalancing the Serotonergic System in Cocaine DependenceWithdrawnNCT03266939Phase 1
• Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot StudyCompletedNCT03244553Phase 2
• Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy VolunteersCompletedNCT03156920Not applicable
• LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety DisordersCompletedNCT03153579Phase 2
• A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer DiseaseStatus unknownNCT03151382Phase 4
• Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency DepartmentCompletedNCT03145467Phase 4
• Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use DisorderTerminatedNCT03143543Phase 1
• Status Migrainosus - Differentiating Between Responders and Non-respondersStatus unknownNCT03066544Phase 1/2
• Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion ProcessingCompletedNCT03019822Early Phase 1
• Gene-by-Stress Interactions in Intervention Studies SignificanceTerminatedNCT03011645Phase 1
• Intensive Blood PRessure Control in Patients With Acute Type B AortIc DissectionStatus unknownNCT03001739Phase 1
• Prucalopride in Postoperative IleusCompletedNCT02947269Phase 3
• Cerebral Pharmacodynamic Effects of 5-HT1B Receptor StimulationTerminatedNCT02932488Phase 1
• Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use DisorderCompletedNCT02932215Phase 1
• A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation PowderCompletedNCT02905227Phase 1
• Prucalopride Prior to Small Bowel Capsule EndoscopyStatus unknownNCT02806206Phase 4
• Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute MigraineCompletedNCT02684409Phase 1
• Lorcaserin Intra Venous Cocaine EffectsStatus unknownNCT02680288Phase 1/2
• Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' DiseaseCompletedNCT02617017Phase 3
• Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy AdultsCompletedNCT02609945Phase 1
• A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 DiabetesStatus unknownNCT02606617Phase 4
• Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced DyskinesiaTerminatedNCT02589340Phase 1
• The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus NicardipineTerminatedNCT02558023Phase 3
• Prucalopride Versus Placebo in GastroparesisTerminatedNCT02510976Phase 4
• The Effect of Sumatriptan and Placebo on Cilostazol Induced HeadacheCompletedNCT02486276Not applicable
• The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced HeadacheCompletedNCT02485340Not applicable
• Mechanistic Investigation Of Intestinal Cytochrome p450 3A4 Following Roux-en-Y Surgery And Its Effect on Plasma Concentrations of BuspironeTerminatedNCT02483598Phase 4
• The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy VolunteersCompletedNCT02451072Not applicable
• A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease PatientsStatus unknownNCT02439125Phase 2
• Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy SubjectsStatus unknownNCT02433847Phase 4
• Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory PathwayCompletedNCT02425774Phase 4
• The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious ProfessionalsCompletedNCT02421263Phase 1
• Lorcaserin in Obesity: Identification of CNS Targets Using fMRIActive, not recruitingNCT02400359Phase 4
• A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of AgeCompletedNCT02398669Phase 1
• Study to Assess Potential Interactions Between Intravenous Cocaine and Oral LorcaserinCompletedNCT02393599Phase 1
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• Spinal Cord Neuromodulation for Spinal Cord InjuryActive, not recruitingNCT02313194Phase 1/2
• Neuronal Correlates of Altered States of ConsciousnessCompletedNCT02308969Early Phase 1
• Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression DisorderStatus unknownNCT02273154Phase 4
• Effects and Mechanism of Mosapride Citrate on Diabetic GastroparesisStatus unknownNCT02264587Phase 4
• Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionCompletedNCT02243813Phase 1
• Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic ConstipationCompletedNCT02228616Phase 4
• A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting ConditionsCompletedNCT02201316Phase 1
• A Study of APD356 (Lorcaserin) in Healthy Japanese Adult SubjectsCompletedNCT02192515Phase 1
• Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen TypeStatus unknownNCT02186366Not applicable
• The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin HormonesCompletedNCT02180334Phase 4
• UW Psilocybin Pharmacokinetics StudyCompletedNCT02163707Phase 1
• A Drug Interaction Study of Mosapride and RebamipideCompletedNCT02106130Phase 1
• Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or PlaceboCompletedNCT02097147Phase 1
• Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With ConstipationCompletedNCT02082457Phase 2
• Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal SurgeryStatus unknownNCT02056405Phase 4
• Tandospirone Combined With Atypical Antipsychotic Drugs in SchizophreniaStatus unknownNCT02040883Phase 4
• Prucalopride Versus Placebo in GastroparesisCompletedNCT02031081Phase 2/3
• The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar DepressivesWithdrawnNCT02028026Phase 4
• Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of AgeCompletedNCT02022956Phase 1
• Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal SurgeryCompletedNCT02004652Phase 2
• Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral SumatriptanCompletedNCT01989936Phase 3
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic ConstipationCompletedNCT01989234Phase 2
• Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsCompletedNCT01988311Phase 1
• Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and PlaceboCompletedNCT01986270Phase 3

← Serotonin Receptor Agonists overview